Welcome to our dedicated page for Philip Morris SEC filings (Ticker: PM), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Philip Morris International Inc. filings document the reporting obligations of a global tobacco and smoke-free products company with NYSE-listed common stock and multiple listed note series. The record includes Form 8-K material-event reports, periodic-report references, proxy materials, and exchange notices covering debt securities.
The company’s disclosures address operating results, risk factors, product and regulatory matters, capital structure, debt listings, shareholder voting, director elections, executive compensation, auditor ratification, shareholder proposals, and notices of removal from listing or registration for specified notes.
Philip Morris International Inc. updated its 2026 earnings outlook while its CEO addresses investors at the 2026 dbAccess Global Consumer Conference. The company now forecasts full-year reported diluted EPS of $7.18 to $7.33, reflecting currency effects and a non-cash impairment related to its Canadian affiliate RBH.
Excluding total forecast adjustments of $1.13 per share, PMI projects adjusted diluted EPS of $8.31 to $8.46 for 2026, a 10.2% to 12.2% increase versus $7.54 in 2025. The company expects to record an approximately $500 million non-cash impairment charge, or $0.33 per diluted share, in the second quarter of 2026 after reassessing RBH’s fair value.
PMI notes that smoke-free products, led by IQOS and including ZYN nicotine pouches, are driving performance and represented 43% of total net revenues in the first quarter of 2026. The company also highlights expansion of its U.S. ZYN portfolio and reiterates that all other forecast assumptions remain unchanged from prior guidance.
Philip Morris International is appointing Massimo Andolina, currently President, Europe Region, as Group Chief Financial Officer effective August 1, 2026, succeeding Emmanuel Babeau. Babeau will remain with the company until March 31, 2027 as Strategic Advisor to Group CEO Jacek Olczak to support a smooth transition.
The company highlights the growth of its smoke-free business, which represented 43% of total net revenues in Q1 2026, with smoke-free products available in over 105 markets and used by an estimated 43 million legal-age consumers as of December 31, 2025. Since 2008, PMI has invested over $16 billion to develop and commercialize smoke-free products.
Philip Morris International is appointing Massimo Andolina, currently President, Europe Region, as Group Chief Financial Officer effective August 1, 2026, succeeding Emmanuel Babeau. Babeau will remain with the company until March 31, 2027 as Strategic Advisor to Group CEO Jacek Olczak to support a smooth transition.
The company highlights the growth of its smoke-free business, which represented 43% of total net revenues in Q1 2026, with smoke-free products available in over 105 markets and used by an estimated 43 million legal-age consumers as of December 31, 2025. Since 2008, PMI has invested over $16 billion to develop and commercialize smoke-free products.
Philip Morris International Inc. ownership disclosure: Capital International Investors amended its Schedule 13G to report beneficial ownership of 74,180,496 shares, representing 4.8% of the 1,558,530,268 shares believed outstanding. The filing shows sole voting power for 73,091,357 shares and sole dispositive power for 74,180,496 shares.
Philip Morris International Inc.—Schedule 13G reporting
Capital Research Global Investors reports beneficial ownership of 79,856,361 shares of Common Stock, equal to 5.1% of 1,558,530,268 shares believed outstanding as of 03/31/2026. The filing shows sole voting power for 79,806,976 shares and sole dispositive power for 79,856,361. The statement is signed by a Capital Research officer on 05/11/2026.
Combes Michel reported acquisition or exercise transactions in this Form 4 filing.
Philip Morris International director Michel Combes received a stock award of 1,119 shares of common stock on May 6, 2026. The grant was made under the Philip Morris International Inc. 2017 Stock Compensation Plan for Non-Employee Directors at an award value based on the average high and low price of $169.93 per share that day.
After this award, Combes directly holds 11,643 shares, including 10,609 deferred shares in the same director stock compensation plan. The deferred share balance increased by 1,439 shares, reflecting the 2026 stock award and 320 deferred shares from dividend reinvestment since the prior reportable transaction.
Philip Morris International Inc. director Werner Geissler acquired 1,119 shares of common stock on May 6, 2026 as a stock award under the company’s 2017 Stock Compensation Plan for Non-Employee Directors at an average price of $169.93 per share. Following this grant, he directly holds 98,356 shares of Philip Morris International common stock. Footnote disclosure indicates this reflects a total increase of 3,940 shares since May 9, 2025, including 2,821 shares accumulated through dividend reinvestment.
Philip Morris International Inc. director Kalpana Morparia reported receiving a grant of common stock as part of board compensation. On May 6, 2026, she acquired 1,119 shares at a reference price of $169.93 per share, based on the average of that day's high and low prices.
These shares were awarded under the Philip Morris International Inc. 2017 Stock Compensation Plan for Non-Employee Directors. Following this award, Morparia directly holds a total of 28,236 shares of Philip Morris International Inc. common stock.
Harker Victoria D reported acquisition or exercise transactions in this Form 4 filing.
Philip Morris International Inc. director Victoria D. Harker received a stock award of 1,119 shares of common stock on May 6, 2026. The grant was made under the company’s 2017 Stock Compensation Plan for Non-Employee Directors at an average reference price of $169.93 per share.
Following this compensation-related grant, Harker directly holds 4,537 shares of Philip Morris International common stock. This filing reflects a routine equity award rather than an open-market purchase or sale.
Polet Robert reported acquisition or exercise transactions in this Form 4 filing.
Philip Morris International Inc. director Robert Polet received a stock award of 1,119 shares of common stock on May 6, 2026. The award was granted under the Philip Morris International Inc. 2017 Stock Compensation Plan for Non-Employee Directors, using an average share price of $169.93 for valuation. Following this grant, Polet directly holds 29,765 shares of Philip Morris International common stock.
Bough Bonin reported acquisition or exercise transactions in this Form 4 filing.
Philip Morris International Inc. director Bough Bonin received a stock award of 1,119 shares of common stock on May 6, 2026, as compensation under the company’s 2017 Stock Compensation Plan for Non-Employee Directors. The award was valued using the average high and low price of $169.93 per share on that date, bringing his directly held and deferred shares reported in this plan to 11,297, including 11,296 deferred shares accumulated through awards and dividend reinvestments.